Managing Asthma Long Term
|
|
- Annabella Davidson
- 2 years ago
- Views:
Transcription
1 Managing Asthma Long Term TARGET POPULATION Eligibility Inclusion Criterion Exclusion Criterion RECOMMENDATIONS F I G U R E 4 2 a. CLASSIFYING ASTHMA SEVERITY AND INITIATING TREATME N T IN CHILDREN 0 4 YEARS OF AGE (Assessing severity and initiating therapy in children who are not currently taking long-term control medication) Conditional: Classification of Asthma Severity (0 4 years of age) {Rec_1: Cond_1 } Value: 0 Value: 1 2x/month Value: 3 4x/month Value: >1x/week Interference with normal activity Value: Minor limitation Value: 0 1/year Value: 2 exacerbations in 6 months requiring oral systemic corticosteroids, or 4 wheezing episodes/1 year lasting >1 day AND risk factors for persistent p. 1 Fri, 15 Aug :05:
2 asthma Recommended Step for Initiating Therapy: Step 1 Recommended Step for Initiating Therapy: Step 2 Recommended Step for Initiating Therapy: Step 3 Conclude: Intermittent Conclude: Mild persistent Conclude: Moderate persistent Conclude: Severe persistent F I G U R E 4 3 a. ASSESSING ASTHMA CONTROL AND ADJUSTING THERAPY I N CHILDREN 0 4 YEARS OF A G E Conditional: Classification of Asthma Control (0 4 years of age) {Rec_2: Cond_2 } Imapirment: Nighttime awakenings Value: 1x/month Value: >1x/month Value: >1x/week p. 2 Fri, 15 Aug :05:
3 Value: 0 1/year Value: 2 3/year Value: >3/year Risk: Treatment-related adverse effects Value: Medication side effects can vary in intensity from none to very troublesome and worrisome. The level of intensity does not correlate to specific levels of control but should be considered in the overall assessment of risk. Conclude: Well Controlled Maintain current treatment. Regular followup every 1 6 months. Consider step down if well controlled for at least 3 months. Conclude: Not well-controlled Step up (1 step) and Reevaluate in 2 6 weeks. If no clear benefit in 4 6 weeks, consider alternative diagnoses or adjusting therapy. For side effects, consider alternative treatment options. Conclude: Very poorly controlled Consider short course of oral systemic corticosteroids, Step up (1 2 steps), and Reevaluate in 2 weeks. If no clear benefit in 4 6 weeks, consider alternative diagnoses or adjusting therapy. For side effects, consider alternative treatment F I G U R E 4 2 b. CLASSIFYING ASTHMA SEVERITY AND INITIATING TREATME N T IN CHILDREN 5 11 Y EARS OF AGE (Assessing severity and initiating therapy in children who are not currently taking long-term control medication) Conditional: Classification of Asthma Severity (5 11 years of age) {Rec_3: Cond_3 } p. 3 Fri, 15 Aug :05:
4 Value: 2x/month Value: 3 4x/month Value: >1x/week but not nightly Value: Often 7x/week Value: Minor limitation Impairment: Lung function Value: Normal FEV1 between exacerbations FEV1 >80% predicted FEV1 /FVC >85% Value: FEV1 = >80% predicted FEV1 /FVC >80% Value: FEV1 = 60 80% predicted FEV1 /FVC = 75 80% Value: FEV1 <60% predicted FEV1 /FVC <75% Value: 0 1/year (see note) Value: 2/year (see note) Intermittent Mild Persistent Moderate Persistent Severe Persistent Recommended Step for Initiating Therapy p. 4 Fri, 15 Aug :05:
5 F I G U R E 4 3 b. ASSESSING ASTHMA CONTROL AND ADJUSTING THERAPY IN CHILDREN 5 11 YEARS OF AGE Conditional: Classification of Asthma Control (5 11 years of age) {Rec_4: Cond_4 } but not more than once on each day or multiple times on 2 days/week Value: 1x/month Value: 2x/month Value: 2x/week Impairment: Lung function FEV1 or peak flow FEV1 /FVC Value: >80% predicted/ personal best >80% Value: 60 80% predicted/ personal best 75 80% Value: <60% predicted/ personal best <75% Value: 0 1/year Value: 2/year (see note) Risk: Reduction in lung growth Risk: Treatment-related adverse effects Recommended Action for Treatment Conclude: Well controlled Conclude: Not well controlled Conclude: Very poorly controlled p. 5 Fri, 15 Aug :05:
6 F I G U R E 4 6. CLASSIFYING ASTHMA SEVERITY AND I N I T I A T I N G TREATMENT IN YOUTHS 12 YEARS OF AGE AND ADULT S Assessing severity and initiating treatment for patients who are not currently taking long-term control medications Conditional: Classification of Asthma Severity 12 years of age {Rec_5: Cond_5 } Value: 2x/month Value: 3 4x/month Value: >1x/week but not nightly Value: Often 7x/week, and not more than 1x on any day Value: Minor limitation Impairment: Lung function Value: Normal FEV1 between exacerbations FEV1 >80% predicted FEV1 /FVC normal Value: FEV1 >80% predicted FEV1 /FVC normal Value: FEV1 >60% but <80% predicted FEV1 /FVC reduced 5% Value: FEV1 <60% predicted FEV1 /FVC reduced >5% Value: 0 1/year (see note) Value: 2/year (see note) p. 6 Fri, 15 Aug :05:
7 Recommended Step for Initiating Treatment F I G U R E 4 6. CLASSIFYING ASTHMA SEVERITY AND I N I T I A T I N G TREATMENT IN YOUTHS 12 YEARS OF AGE AND ADULT S Assessing severity and initiating treatment for patients who are not currently taking long-term control medications Conditional: Classification of Asthma Control (12 years of age) {Rec_6: Cond_6 } Value: 2x/month Value: 1 3x/week Value: 4x/week Impairment: FEV1 or peak flow Value: >80% predicted/ personal best Value: 60 80% predicted/ personal best Value: <60% predicted/ personal best Impairment: Validated questionnaires: ATAQ ACQ ACT Value: * 20 Value: Value: 3 4 N/A 15 p. 7 Fri, 15 Aug :05:
8 Value: 0 1/year Value: 2/year (see note) Risk : Progressive loss of lung function Value: Evaluation requires long-term followup care Risk: Treatment-related adverse effects Value: Medication side effects can vary in intensity from none to very troublesome and worrisome. The level of intensity does not correlate to specific levels of control but should be considered in the overall assessment of risk. Recommended Action for Treatment Conclude: Well Controlled Conclude: Not Well Controlled Conclude: Very Poorly Controlled p. 8 Fri, 15 Aug :05:
Classifying Asthma Severity and Initiating Treatment in Children 0 4 Years of Age
Classifying Asthma Severity and Initiating Treatment in Children 0 4 Years of Age Components of Severity Symptoms Intermittent 2 days/week Classification of Asthma Severity (0 4 years of age) Persistent
Spirometry Workshop for Primary Care Nurse Practitioners
Spirometry Workshop for Primary Care Nurse Practitioners Catherine Casey S. Jones PhD, RN, AE-C, ANP-C Certified Adult Nurse Practitioner Texas Pulmonary & Critical Care Consultants P.A. and Visiting Assistant
Training Manual & Speaker s Guide
Training Manual & Speaker s Guide Based on National Asthma Education and Prevention Program (NAEPP) Guidelines including the NAEPP s Guidelines Implementation Panel (GIP) Priority Messages. Funded in part
Differentiating Asthma from COPD: Role of History, Physical Examination, Laboratory Studies, and Lung Function Testing
Differentiating Asthma from COPD: Role of History, Physical Examination, Laboratory Studies, and Lung Function Testing Stephen P Peters, MD, PhD, FAAAAI Professor of Medicine, Pediatrics and Translational
Annotated from the NAEPP/NHLBI Updated Asthma Guidelines and Developed Through Expert Consensus
Asthma Pocket Guide for Primary Care Annotated from the NAEPP/NHLBI Updated Asthma Guidelines and Developed Through Expert Consensus POSITION STATEMENT Despite advances in therapy, asthma remains a disease
Diagnosis, Evaluation and Management of Adults and Children with Asthma
Clinical Guideline for the Diagnosis, Evaluation and Management of Adults and Children with Asthma Color Key n Four Components of Asthma Care n Classifying Asthma Severity, Assessing Asthma Control and
Service Specification
Service Specification Spirometry in Primary Care Date: February 2011 Document Reference: Service Specification (V4.0) Contents: Section Page 1 Definition of service 3 2 Training 4 3 Reporting / Monitoring
Dear Provider: Sincerely,
Asthma Toolkit Dear Provider: L.A. Care is pleased to present this updated asthma toolkit. Our goal is to promote the highest level of asthma care, based on the 2007 National Asthma Education and Prevention
Subject ID: Subject Initials Date completed Interviewer. Person answering questions. 1 yes 2 no
COAST III Childhood Origins of ASThma Asthma Allergy Symptoms COAST 3 year visit Subject ID Subject ID: Subject Initials Date completed Interviewer Person answering questions 99. This form was completed
THE ASTHMA SYMPTOM UTILITY INDEX: RELIABILITY, VALIDITY, AND RESPONSIVENESS AMONG ADULT ASTHMA PATIENTS. Christian Bime A THESIS
THE ASTHMA SYMPTOM UTILITY INDEX: RELIABILITY, VALIDITY, AND RESPONSIVENESS AMONG ADULT ASTHMA PATIENTS By Christian Bime A THESIS Submitted to Michigan State University in partial fulfillment of the requirements
Mepolizumab (Nucala ) for Treatment of Severe Asthma with Eosinophilic Inflammation: Effectiveness, Value, and Value-Based Price Benchmarks
Mepolizumab (Nucala ) for Treatment of Severe Asthma with Eosinophilic Inflammation: Effectiveness, Value, and Value-Based Price Benchmarks Final Background and Scope November 18, 2015 Background: The
Exploratory data: COPD and blood eosinophils. David Price: 9.23-9.35am
Exploratory data: COPD and blood eosinophils David Price: 9.23-9.35am Blood Eosinophilia in COPD The reliability and utility of blood eosinophils as a marker of disease burden, healthcare resource utilisation
WAY OF WORKING LUNG PATIENTS
WAY OF WORKING LUNG PATIENTS CELLO Leiden May 2011 Introduction CELLO, the cooperation of primary health care practitioners in Leiden and surroundings, is an organisation of independently working general
Severe asthma Definition, epidemiology and risk factors. Mina Gaga Athens Chest Hospital
Severe asthma Definition, epidemiology and risk factors Mina Gaga Athens Chest Hospital Difficult asthma Defined as asthma, poorly controlled in terms of chronic symptoms, with episodic exacerbations,
Pain, Coping and Sleep in Children and Adolescents With Sickle Cell Disease J. Kelly Graves, PhD, RN Eufemia Jacob, PhD, RN
Pain, Coping and Sleep in Children and Adolescents With Sickle Cell Disease J. Kelly Graves, PhD, RN Eufemia Jacob, PhD, RN Sigma Theta Tau International 24 th International Nursing Research Congress July
Spirometry: Performance and Interpretation. A Guide for General Practitioners
Irish Thoracic Society Spirometry: Performance and Interpretation A Guide for General Practitioners Dr. Terry O Connor, Consultant Respiratory Physician, Mercy University Hospital, Cork Dr. Pat Manning,
Logistics. Registration for free continuing education (CE) hours or certificate of attendance through TRAIN at: https://tx.train.
. DSHS Grand Rounds Logistics Registration for free continuing education (CE) hours or certificate of attendance through TRAIN at: https://tx.train.org Streamlined registration for individuals not requesting
MEDICAL POLICY STATEMENT
MEDICAL POLICY STATEMENT Original Effective Date Next Annual Review Date Last Review / Revision Date 06/15/2011 02/15/2017 03/09/2016 Policy Name Policy Number Xolair/Nucala SRx-0013 Policy Type Medical
The National Asthma Education. Overview of Changes to Asthma Guidelines: Diagnosis and Screening
Overview of Changes to Asthma Guidelines: Diagnosis and Screening SUSAN M. POLLART, MD, MS, and KURTIS S. ELWARD, MD, MPH Department of Family Medicine, University of Virginia School of Medicine, Charlottesville,
Pre-Operative Services Teaching Rounds 2 Jan 2011
Pre-Operative Services Teaching Rounds 2 Jan 2011 Deborah Richman MBChB FFA(SA) Director Pre-Operative Services Department of Anesthesia Stony Brook University Medical Center, NY drichman@notes.cc.sunysb.edu
Asthma. Micah Long, MD
Asthma Micah Long, MD Goals Define the two components of asthma. Describe the method of action and uses for: Steroids (inhaled and IV) Quick Beta Agonists (Nebs and MDIs) The "Others" Magnesium, Epi IM,
Respiratory Impairment and Disability Assessment. Impairment/Disability. Impairment/Disability WOEMA Webinar Series / April 29, 2015
Conflict of Interest Disclosure Respiratory Impairment and Disability Assessment John R. Balmes, MD UCSF PLEASE STAND BY Webinar will begin at 12:00 PM PST FOR AUDIO: CALL 866-740-1260 / ACCESS CODE: 764-4915
An Overview of Asthma - Diagnosis and Treatment
An Overview of Asthma - Diagnosis and Treatment Asthma is a common chronic disorder of the airways that is complex and characterized by variable and recurring symptoms, airflow obstruction, bronchial hyperresponsiveness,
In the last few decades, asthma has become epidemic. As the most common
Licensed School Nurse/ Public Health Nurse/ Registered Nurse In the last few decades, asthma has become epidemic. As the most common chronic childhood disease, asthma affects more than six million children
PULMONARY FUNCTION TESTS A Workshop on Simple Spirometry & Flow Volume Loops
PULMONARY FUNCTION TESTS A Workshop on Simple Spirometry & Flow Volume Loops YOU SHOULD READ THE FOLLOWING MATERIAL BEFORE Tuesday March 30 Interpretation of PFTs Learning Objectives 1. Specify the indications
The Annual Direct Care of Asthma
The Annual Direct Care of Asthma The annual direct health care cost of asthma in the United States is approximately $11.5 billion; indirect costs (e.g. lost productivity) add another $4.6 billion for a
A Disease Management Program in France : Lessons from the RESALIS Experiment 18 Months Before and 12 Months After Public Health Interventions
4 th European Conference on Health Economics Université Paris V. 7-10 July 2002 A Disease Management Program in France : Lessons from the RESALIS Experiment 18 Months Before and 12 Months After Public
COPD and Asthma Differential Diagnosis
COPD and Asthma Differential Diagnosis Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death in America. Learning Objectives Use tools to effectively diagnose chronic obstructive
Scottish Medicines Consortium
Scottish Medicines Consortium salmeterol/fluticasone 50/500 micrograms inhaler (Seretide 500 Accuhaler ) No. (450/08) GlaxoSmithKline 11 February 2008 The Scottish Medicines Consortium has completed its
Breathe With Ease. Asthma Disease Management Program
Breathe With Ease Asthma Disease Management Program MOLINA Breathe With Ease Pediatric and Adult Asthma Disease Management Program Background According to the National Asthma Education and Prevention Program
Objectives. Asthma Management
Objectives Asthma Management BREATHE Conference Allergy and Asthma Specialists PC Christine Malloy MD March 22, 2013 Review the role of inflammation in asthma Discuss the components of the EPR-3 management
PTE Pediatric Asthma Metrics Reporting Updated January 2015
PTE Pediatric Asthma Metrics Reporting Updated January 20 Introduction: The Maine Health Management Coalition s (MHMC) Pathways to Excellence (PTE) Program is preparing for its next round of PTE Pediatric
This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.
abcd Clinical Study for Public Disclosure This clinical study synopsis is provided in line with s Policy on Transparency and Publication of Clinical Study Data. The synopsis which is part of the clinical
Respiratory Reviews in Asthma 2013. Tae-Hyung Kim, M.D. Hanyang University College of Medicine
Respiratory Reviews in Asthma 2013 Tae-Hyung Kim, M.D. Hanyang University College of Medicine Contents New treatment options Effect of treatment adjustment Useful diagnostic markers in asthma Scoring systems
This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.
abcd Clinical Study for Public Disclosure This clinical study synopsis is provided in line with s Policy on Transparency and Publication of Clinical Study Data. The synopsis which is part of the clinical
How to use FENO-guided asthma control in routine clinical practice
How to use FENO-guided asthma control in routine clinical practice Asthma is a chronic inflammatory disease of the airways. This has implications for the diagnosis, management and potential prevention
Asthma. When do these symptoms arise? What triggers make asthma worse?
Asthma Asthma is the term which describes a specific type of breathing problem that arises due to narrowing of the airways. This narrowing is caused when certain natural chemicals within the body are released,
Tests. Pulmonary Functions
Pulmonary Functions Tests Static lung functions volumes Dynamic lung functions volume and velocity Dynamic Tests Velocity dependent on Airway resistance Resistance of lung tissue to change in shape Dynamic
Pharmacy Management Drug Policy
PAGE: Page 1 of 5 DESCRIPTION: Asthma is a heterogeneous syndrome that might be better described as a constellation of phenotypes, each with distinct cellular and molecular mechanisms, rather than as a
Samer El Rayess, M.D. Internal Medicine, PGY3 29 January 2016
Samer El Rayess, M.D. Internal Medicine, PGY3 29 January 2016 Case Scenario Mr. X., a 50 year old man heavy smoker 80 pack / year known to have -COPD on spiriva at home last exacerbation 9 months ago -Hypertension
Management of Asthma
Federal Bureau of Prisons Clinical Practice Guidelines May 2013 Clinical guidelines are made available to the public for informational purposes only. The Federal Bureau of Prisons (BOP) does not warrant
Confirming Diagnosis Through Spirometry
Confirming Diagnosis Through Spirometry Shirley F. Jones, M.D., FCCP I have no conflicts of interest Instructional Objectives At the end of this session, learners will be able to: Select individual patients
Diagnosing Asthma: Spirometry & interpretation in the primary care practice setting, Yes, it CAN be done!
Diagnosing Asthma: Spirometry & interpretation in the primary care practice setting, Yes, it CAN be done! Joseph P Buhain MBA RRT FAARC NREMTB Saint Paul College Director of Respiratory Therapy and Simulation
Sponsor Novartis Pharmaceuticals
Clinical Trial Results Database Page 1 Sponsor Novartis Pharmaceuticals Generic Drug Name Indacaterol Therapeutic Area of Trial Chronic Obstructive Pulmonary Disease (COPD) Indication studied: COPD Study
Pulmonary Rehabilitation: Billing & Coding Medicare Guidelines
Pulmonary Rehabilitation: Billing & Coding Medicare Guidelines Deborah Recko, MN, RN-BC, CCRP Clinical Coordinator, Cardiac & Pulmonary Rehab University Hospitals St. John Medical Center Westlake, Ohio
On completion of this chapter you should be able to: discuss the stepwise approach to the pharmacological management of asthma in children
7 Asthma Asthma is a common disease in children and its incidence has been increasing in recent years. Between 10-15% of children have been diagnosed with asthma. It is therefore a condition that pharmacists
Stanley J. Szefler, MD National Jewish Medical and Research Center
New Asthma Guidelines: Special Attention to Infant Wheezers Stanley J. Szefler, MD Helen Wohlberg & Herman Lambert Chair in Pharmacokinetics, & Professor of Pediatrics and Pharmacology, University of Colorado
Measuring Peak Flow. More on next page. Learn more about your health care.
Measuring Peak Flow Peak flow meters are used to check your asthma the way that blood pressure cuffs are used to check high blood pressure. A peak flow meter is a device that measures how well (how fast)
Guideline on the clinical investigation of medicinal products for the treatment of asthma
22 October 2015 CHMP/EWP/2922/01 Rev.1 Committee for Medicinal Products for Human Use (CHMP) Guideline on the clinical investigation of medicinal products for the treatment of Draft Agreed by Respiratory
2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY
Measure #218 (NQF 0423): Functional Deficit: Change in Risk-Adjusted Functional Status for Patients with Hip Impairments National Quality Strategy Domain: Communication and Care Coordination 2016 PQRS
Drug: mepolizumab (Nucala) Class: Interleukin-5 Receptor Antagonist Line of Business: Non-Medicare Effective Date: February 17, 2016.
This policy has been developed through review of medical literature, consideration of medical necessity, generally accepted medical practice standards, and approved by the IEHP Pharmacy and Therapeutics
The pharmacist s role in controlling asthma American Pharmacists Association
CPE The pharmacist s role in controlling asthma American Pharmacists Association Abstract Objective: To provide a review of the asthma management guidelines issued by the National Asthma Education and
TB and COPD 衛生福利部胸腔病院 張祐泟醫師
TB and COPD 衛生福利部胸腔病院 張祐泟醫師 COPD is estimated to affect 65 million people worldwide COPD predicted to be third leading cause of death in 2030 3 million deaths annually 90 % of these deaths are in low-
Medical Policy An independent licensee of the Blue Cross Blue Shield Association
Afrezza Page 1 of 6 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Afrezza (human insulin) Prime Therapeutics will review Prior Authorization requests Prior Authorization
COPD Prescribing Guidelines
South Staffordshire Area Prescribing Group COPD Prescribing Guidelines Inhaler choices in this guideline are different from previous versions produced by the APG. It is not expected patients controlled
Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD)
Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD) Harvard Vanguard Medical Associates Case Study Organization Profile Founded in the 1960s, Harvard Vanguard Medical
What You Should Know About ASTHMA
What You Should Know About ASTHMA 200 Hospital Drive Galax, VA 24333 (276) 236-8181 www.tcrh.org WHAT IS ASTHMA? It s a lung condition that makes breathing difficult. The cause of asthma is not known.
GOVERNMENT OF INDIA AERONAUTICAL INFORMATION SERVICES DIRECTOR GENERAL OF CIVIL AVIATION OPPOSITE SAFDARJUNG AIRPORT NEW DELHI
Telephone No. 2:4622495 Telegraphic Address: Commercial : AIRCIVIL NEW DELHI Aeronautical : VIDDYAYX E Mail: dri@dgca.nic.in Fax : 01124629221 GOVERNMENT OF INDIA AERONAUTICAL INFORMATION SERVICES DIRECTOR
Recommended Component: Facilitate Linkages with the Medical Home and Referrals to Medical Provider
Recommended Component: Facilitate Linkages with the Medical Home and Referrals to Medical Provider Whenever they identify an unmet need, schools are responsible for referring and helping to manage a student
Asthma POEMs. Patient Orientated Evidence that Matters
ASTHMA POEMs Asthma POEMs Patient Orientated Evidence that Matters Developed by the Best Practice Advocacy Centre Level 8, 10 George Street PO Box 6032 Dunedin Phone 03 4775418 Fax 03 4772622 Acknowledgement
Pediatric. Updated 2008
A S T H M A P R O V I D E R M A N U A L Pediatric Updated 2008 Asthma 2 Causes of Asthma 3 Utah Prevalence 3 Diagnosis 7 Managing Asthma 9 Education for Partnership in Care 11 Control of Environmental
CF ATLANTA Research & Development Program at Emory University and Georgia Tech (CF@LANTA) Clinical & Translational Research Core
CF ATLANTA Research & Development Program at Emory University and Georgia Tech (CF@LANTA) Clinical & Translational Research Core Arlene Stecenko, MD Director, Emory + Children s Cystic Fibrosis Care Center
CCHCS Care Guide: Asthma
GOALS SHORTNESS OF BREATH, WHEEZE, COUGH NIGHT TIME AWAKENINGS ACTIVITY INTERFERENCE SABA* USE FOR SYMPTOM CONTROL FEV1* OR PEAK FLOW EXACERBATIONS REQUIRING ORAL STEROIDS < 2 DAYS / WEEK 2 TIMES / MONTH
COPD MANAGEMENT PROTOCOL STANFORD COORDINATED CARE
I. PURPOSE To establish guidelines f the collabative management of patients with a diagnosis of chronic obstructive pulmonary disease (COPD) who are not adequately controlled and to define the roles and
MINISTERIO DE SALUD PUBLICA DIRECCION PROVINCIAL DE SALUD DEL GUAYAS HOSPITAL DE INFECTOLOGIA DR. JOSE DANIEL RODRIGUEZ MARIDUEÑA Guayaquil - Ecuador
EVALUATION OF THE EFFECTIVENESS OF THE PRODUCT BABUNA IN THE TREATMENT OF INSOMNIA, IN PATIENTS OF THE MALE WING OF THE ECUADORIAN HEALTH MINISTRY S HOSPITAL OF INFECTIOUS DISEASE PILLASAGUA Diana, ANDINO
SUMMARY OF RECOMMENDATIONS FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
SUMMARY OF RECOMMENDATIONS FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) Diagnosis and diagnostic tools Recommendation 1 Diagnosis of COPD (IV) It is recommended that spirometry should be performed
understanding the professional guidelines
SEVERE ASTHMA understanding the professional guidelines This guide includes information on what the European Respiratory Society (ERS) and the American Thoracic Society (ATS) have said about severe asthma.
Which smokers develop COPD? A prediction rule. Geijer RMM Sachs APE Verheij TJM Zuithoff, NPA Lammers J-WJ Hoes AW
5 Which smokers develop COPD? A prediction rule Geijer RMM Sachs APE Verheij TJM Zuithoff, NPA Lammers J-WJ Hoes AW 54 Prediction of moderate COPD Introduction Tobacco smoking is the main risk factor for
Guidance to support the stepwise review of combination inhaled corticosteroid therapy for adults ( 18yrs) in asthma
Guidance to support the stepwise review of combination inhaled corticosteroid therapy for adults ( 18yrs) in asthma Important Complete asthma control needs to be achieved for at least 12 weeks before attempting
The patient s response to therapy within the first hour in the Emergency Room is one of the most reliable ways to predict need for hospitalization.
Emergency Room Asthma Management Algorithm The Emergency Room Asthma Management Algorithm is to be used for any patient seen in the Emergency Room with the diagnosis of asthma. (The initial history should
National Learning Objectives for COPD Educators
National Learning Objectives for COPD Educators National Learning Objectives for COPD Educators The COPD Educator will be able to achieve the following objectives. Performance objectives, denoted by the
Information for Behavioral Health Providers in Primary Care. Asthma
What is Asthma? Information for Behavioral Health Providers in Primary Care Asthma Asthma (AZ-ma) is a chronic (long-term) lung disease that inflames and narrows the airways. Asthma causes recurring periods
Note for guidance on clinical investigation of medicinal products for treatment of asthma
1 2 3 27 June 2013 CHMP/EWP/2922/01 Rev.1 Committee for Medicinal Products for Human Use (CHMP) 4 5 6 Note for guidance on clinical investigation of medicinal products for treatment of asthma Draft Draft
Asthma Intervention. An Independent Licensee of the Blue Cross and Blue Shield Association.
Asthma Intervention 1. Primary disease education Member will have an increased understanding of asthma and the classification by severity, the risks and the complications. Define asthma Explain how lungs
5. Treatment of Asthma in Children
Treatment of sthma in hildren 5. Treatment of sthma in hildren 5.1 Maintenance Treatment 5.1.1 rugs Inhaled Glucocorticoids. Persistent wheezing in children under the age of three can be controlled with
The Asthma Working Group On the Path to Success
The Asthma Working Group On the Path to Success SIXTH ANNUAL PATIENT-REPORTED OUTCOME CONSORTIUM WORKSHOP April 29-30, 2015 Silver Spring, MD Disclaimer The views and opinions expressed in the following
FIBROGENIC DUST EXPOSURE
FIBROGENIC DUST EXPOSURE (ASBESTOS & SILICA) WORKER S MEDICAL SCREENING GUIDELINE Prepared By Dr. T. D. Redekop Chief Occupational Medical Officer Workplace Safety & Health Division Manitoba Labour & Immigration
1. ML is a 14-month-old girl diagnosed with acute otitis media. She presented to the pediatric
1 Chapter 72, Self-Assessment Questions 1. ML is a 14-month-old girl diagnosed with acute otitis media. She presented to the pediatric clinic today with a fever of 102.4 F (39.1 C) and tugging of her right
QUESTIONS FOR YOUR LUNG CANCER CARE TEAM
What should I ask my doctor? Thinking about lung cancer brings up many questions. Sometimes it is difficult to keep all of your questions straight. Many patients have topics in mind they want to discuss
Managing depression after stroke. Presented by Maree Hackett
Managing depression after stroke Presented by Maree Hackett After stroke Physical changes We can see these Depression Emotionalism Anxiety Confusion Communication problems What is depression? Category
Clinical Study Synopsis
Clinical Study Synopsis This file is posted on the Bayer HealthCare Clinical Trials Registry and Results website. It is provided for patients and healthcare professionals to increase the transparency of
Final Report. March 14, 2016. Institute for Clinical and Economic Review
Mepolizumab (Nucala, GlaxoSmithKline plc.) for the Treatment of Severe Asthma with Eosinophilia: Effectiveness, Value, and Value- Based Price Benchmarks Final Report March 14, 2016 Institute for Clinical
Pathway for Diagnosing COPD
Pathway for Diagnosing Visit 1 Registry Clients at Risk Patient presents with symptoms suggestive of Exertional breathlessness Chronic cough Regular sputum production Frequent bronchitis ; wheeze Occupational
LEVEL I SA: OUTPATIENT INDIVIDUAL THERAPY - Adult
LEVEL I SA: OUTPATIENT INDIVIDUAL THERAPY - Adult Definition The following is based on the Adult Criteria of the Patient Placement Criteria for the Treatment of Substance-Related Disorders of the American
PLAN OF ACTION FOR. Physician Name Signature License Date
PLAN OF ACTION FOR Patient s copy (patient s name) I Feel Well Lignes I feel short directrices of breath: I cough up sputum daily. No Yes, colour: I cough regularly. No Yes I Feel Worse I have changes
DEPRESSION Depression Assessment PHQ-9 Screening tool Depression treatment Treatment flow chart Medications Patient Resource
E-Resource March, 2015 DEPRESSION Depression Assessment PHQ-9 Screening tool Depression treatment Treatment flow chart Medications Patient Resource Depression affects approximately 20% of the general population
Spirometry. Sonia Munde. Senior Respiratory Care Physiologist Adult Respiratory Care & Rehab Team Barts Health
Spirometry Sonia Munde Senior Respiratory Care Physiologist Adult Respiratory Care & Rehab Team Barts Health COPD Definition.airflow obstruction is usually progressive, not fully reversible and does not
American Thoracic Society Documents
American Thoracic Society Documents An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations Standardizing Endpoints for Clinical Asthma Trials and
Reducing Environmental Triggers of Asthma in Homes of Minnesota Children
Reducing Environmental Triggers of Asthma in Homes of Minnesota Children Assistance Agreement Number CH-96541501 United States Environmental Protection Agency Asthma Program Chronic Disease and Environmental
Update in ASTHMA and COPD: Clearing the Air What Works and What Doesn t?
Update in ASTHMA and COPD: Clearing the Air What Works and What Doesn t? Blair Brooks MD Dartmouth Hitchcock Medical Center Community Faculty Development Symposium 11/05/04 Knowing is not enough: we must
AHS s Headache Coding Corner A user-friendly guide to CPT and ICD coding
AHS s Headache Coding Corner A user-friendly guide to CPT and ICD coding Stuart Black, MD Part 3 - Medical Decision Making (MDM) coding in Headache As stated in the CPT codebook, the classification of
Update on COPD and Asthma. October 17 th, 2015 Rachel M Taliercio, DO Staff, Respiratory Institute, Cleveland Clinic
Update on COPD and Asthma October 17 th, 2015 Rachel M Taliercio, DO Staff, Respiratory Institute, Cleveland Clinic What we ll be talking about Update on COPD Diagnosis, management of stable COPD, COPD
Part 1: Depression Screening in Primary Care
Part 1: Depression Screening in Primary Care Toni Johnson, MD Kristen Palcisco, BA, MSN, APRN MetroHealth System Objectives Part 1: Improve ability to screen and diagnose Depression in Primary Care Increase
Measuring fractional exhaled nitric oxide concentration in asthma: NIOX MINO, NIOX VERO and NObreath
Measuring fractional exhaled nitric oxide concentration in asthma: NIOX MINO, NIOX VERO and NObreath Issued: April 2014 www.nice.org.uk/dg12 NICE has accredited the process used by the Centre for Health
Updated guidelines on headache management for use by the pharmacist
M I P C A MIGRAINE IN PRIMARY CARE ADVISORS Updated guidelines on headache management for use by the pharmacist Introduction N U M B E R 2 1, O C T O B E R 2 0 1 2 Headache is a major public health problem,
Where kids come first. Childhood asthma
14 Where kids come first Childhood asthma In Canada, childhood asthma has quadrupled in the last decade. It is one of the most common reasons children are hospitalized or visit emergency departments. A
PATIENT GROUP DIRECTION (PGD) ADMINISTRATION OF INHALED SALBUTAMOL FOR THE EMERGENCY TREATMENT OF ACUTE ASTHMA OR COPD EXACERBATION AT HMP FORD
PATIENT GROUP DIRECTION (PGD) ADMINISTRATION OF INHALED SALBUTAMOL FOR THE EMERGENCY TREATMENT OF ACUTE ASTHMA OR COPD EXACERBATION AT HMP FORD Version Number: 01HMP Patient Group Direction originally
Lothian Guideline for Domiciliary Oxygen Therapy Service for COPD
Lothian Guideline for Domiciliary Oxygen Therapy Service for COPD This document describes the standard for clinical assessment, prescription, optimal management and follow-up of patients receiving domiciliary